News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2025.11.01
Notice of Consulting Services Contract Conclusion with New Securities Firm
(242KB)
-
2025.10.22
Announcement of Completion of Patient Enrollment for the Phase IIa Clinical Trial of PC-SOD
(261KB)
-
2025.09.24
Our CEO (Director of the Japan Biotechnology Association) made a statement at the Central Social Insurance Medical Council
(248KB)
-
2025.09.11
Report on the Conduct of the PC-SOD Phase III Clinical Trial Investigator Meeting
(536KB)
-
2025.09.10
Request for notification of changes to shareholder register entries, such as address changes
(251KB)
-
2025.08.21
Announcement Regarding Initiation of Phase III Clinical Trial of PC-SOD for CIPN
(265KB)
-
2025.08.06
Negotiations with European pharmaceutical company regarding PC-SOD license agreement
(276KB)
-
2025.07.31
Notice Regarding the Conclusion of a Joint Research Agreement
(156KB)
-
2025.07.23
Announcement of Joint Research Agreement with Yamaguchi University
(150KB)
-
2025.07.23
Notice Regarding the Conclusion of a Joint Research Agreement
(138KB)
